Corrigendum: Candidate gene resequencing in a large bicuspid aortic valve-associated thoracic aortic aneurysm cohort: SMAD6 as an important contributor [Front. Physiol, 8, (2017) (400)] doi: 10.3389/fphys.2017.00400 by Gillis, E. (Elisabeth) et al.
CORRECTION
published: 25 September 2017
doi: 10.3389/fphys.2017.00730
Frontiers in Physiology | www.frontiersin.org 1 September 2017 | Volume 8 | Article 730
Edited and reviewed by:
Gerald A. Meininger,
University of Missouri, United States
*Correspondence:
Bart L. Loeys
bart.loeys@uantwerpen.be
†
These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Vascular Physiology,
a section of the journal
Frontiers in Physiology
Received: 09 August 2017
Accepted: 08 September 2017
Published: 25 September 2017
Citation:
Gillis E, Kumar AA, Luyckx I, Preuss C,
Cannaerts E, van de Beek G,
Wieschendorf B, Alaerts M, Bolar N,
Vandeweyer G, Meester J,
Wünnemann F, Gould RA, Zhurayev R,
Zerbino D, Mohamed SA, Mital S,
Mertens L, Björck HM,
Franco-Cereceda A, McCallion AS,
Van Laer L, Verhagen JMA, van de
Laar IMBH, Wessels MW, Messas E,
Goudot G, Nemcikova M, Krebsova A,
Kempers M, Salemink S,
Duijnhouwer T, Jeunemaitre X,
Albuisson J, Eriksson P, Andelfinger G,
Dietz HC, Verstraeten A, Loeys BL
and Mibava Leducq Consortium
(2017) Corrigendum: Candidate Gene
Resequencing in a Large Bicuspid
Aortic Valve-Associated Thoracic
Aortic Aneurysm Cohort: SMAD6 as
an Important Contributor.
Front. Physiol. 8:730.
doi: 10.3389/fphys.2017.00730
Corrigendum: Candidate Gene
Resequencing in a Large Bicuspid
Aortic Valve-Associated Thoracic
Aortic Aneurysm Cohort: SMAD6 as
an Important Contributor
Elisabeth Gillis 1†, Ajay A. Kumar 1†, Ilse Luyckx 1, Christoph Preuss 2, Elyssa Cannaerts 1,
Gerarda van de Beek 1, Björn Wieschendorf 1, 3, Maaike Alaerts 1, Nikhita Bolar 1,
Geert Vandeweyer 1, Josephina Meester 1, Florian Wünnemann 2, Russell A. Gould 4,
Rustam Zhurayev 5, Dmytro Zerbino 5, Salah A. Mohamed 3, Seema Mital 6, Luc Mertens 6,
Hanna M. Björck 7, Anders Franco-Cereceda 8, Andrew S. McCallion 4, Lut Van Laer 1,
Judith M. A. Verhagen 9, Ingrid M. B. H. van de Laar 9, Marja W. Wessels 9,
Emmanuel Messas 10, Guillaume Goudot 10, Michaela Nemcikova 11, Alice Krebsova 12,
Marlies Kempers 13, Simone Salemink 13, Toon Duijnhouwer 13, Xavier Jeunemaitre 10,
Juliette Albuisson 10, Per Eriksson 7, Gregor Andelfinger 2, Harry C. Dietz 4, 14,
Aline Verstraeten 1, Bart L. Loeys 1, 13* and Mibava Leducq Consortium
1 Faculty of Medicine and Health Sciences, Center of Medical Genetics, University of Antwerp and Antwerp University
Hospital, Antwerp, Belgium, 2Cardiovascular Genetics, Department of Pediatrics, CHU Sainte-Justine, Université de
Montreal, Montreal, QC, Canada, 3Department of Cardiac and Thoracic Vascular Surgery, University Hospital
Schleswig-Holstein, Lübeck, Germany, 4McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School
of Medicine, Baltimore, MD, United States, 5Department of Clinical Pathology, Lviv National Medical University after Danylo
Halytsky, Lviv, Ukraine, 6Cardiovascular Research, SickKids University Hospital, Toronto, ON, Canada, 7Cardiovascular
Medicine Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, 8Cardiothoracic Surgery Unit, Department
of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden, 9Department of Clinical Genetics, Erasmus
University Medical Center, Rotterdam, Netherlands, 10 Assistance Publique–Hôpitaux de Paris, Hôpital Européen Georges
Pompidou; Université Paris Descartes, Paris Sorbonne Cité; Institut National de la Santé et de la Recherche Médicale,
UMRS, Paris, France, 11Department of Biology and Medical Genetics, 2nd Faculty of Medicine-Charles University and Motol
University Hospital, Prague, Czechia, 12 Institute of Clinical and Experimental Medicine, Prague, Czechia, 13Department of
Human Genetics, Radboud University Medical Centre, Nijmegen, Netherlands, 14Howard Hughes Medical Institute,
Baltimore, MD, United States
Keywords: bicuspid aortic valve, thoracic aortic aneurysm, SMAD6, targeted gene panel, variant burden test
A corrigendum on
Candidate Gene Resequencing in a Large Bicuspid Aortic Valve-Associated Thoracic Aortic
Aneurysm Cohort: SMAD6 as an Important Contributor
by Gillis, E., Kumar, A. A., Luyckx, I., Preuss, C., Cannaerts, E., van de Beek, G., et al. (2017). Front.
Physiol. 8:400. doi: 10.3389/fphys.2017.00400
In the original article, we noted two mutation annotation errors. The correction of these two
mistakes does not change the scientific conclusions in any way. The authors apologize for these
nomenclature errors. Please find below the corrected annotations of those two mutations:
(1) The correct RNA and protein annotations of the SMAD6 variant in P99 are c.455_461del
and p.Pro152Profs∗27, and not c.454_461del and p.Gly166Valfs∗23.
(2) The correct RNA and protein annotations of the SMAD6 variant in P128 are c.74_79del and
p.Ser27_Gly28del, and not c.73_79del and p.Gly26_Ser27del.
As a consequence, a correction has been made to RESULTS, Paragraphs 5 and 6:
Gillis et al. SMAD6 Mutations Infer BAV/TAA Risk
FIGURE 2 | Graphical representation of the identified SMAD6 variants. SMAD6 has two major protein domains, a DNA-binding MH1 domain and a MH2 domain that
interacts with components of the TGF-β and BMP signaling pathways. Variants above the protein have been found in patients, while those below the protein occurred
in control individuals. Variants in blue are absent from the ExAC database, variants in orange have an ExAC MAF below 0.01%. TGF-β, Transforming growth factor-β;
BMP, Bone morphogenetic protein; ExAC, Exome Aggregation Consortium; MAF, Minor Allele frequency.
The SMAD6 c.726del variant leads to a frameshift
(p.Lys242Asnfs∗300) and a predicted protein with a C-
terminal extension due to loss of the intended stop codon. The
c.455_461del frameshift variant (p.Pro152Profs∗27) causes the
introduction of a premature stop codon, most likely resulting
in haploinsufficiency due to nonsense-mediated mRNA decay
(NMD). Also the two nonsense variants (p.Tyr279∗ and
p.Tyr288∗) are predicted to lead to NMD. All of the missense
variants cluster in the functionally important MH1 and MH2
domains (Makkar et al., 2009) (amino acids 148–275 and
331–496, respectively), which is not the case for the sole missense
variant (p.Ser130Leu) found in a control individual (Figure 2).
All but one (p.Arg443His) of the identified variants were absent
in the ExAC control cohort (v0.3.1; Supplementary Table 2).
Moreover, the missense variants in the patient cohort (7/7) are
enriched in the MH1 and MH2 domains when compared to
ExAC controls (n= 228/430; p= 0.02).
For two SMAD6 mutation carriers (P89, p.Gly271Glu; P99,
p.Pro152Profs∗27), gDNA of family members was available for
segregation analysis (Supplementary Figure 1). Although neither
of these probands had a documented family history of BAV/TAA,
a brother of P89 has been diagnosed with a sinus of Valsalva
aneurysm (45 mm) and carried the SMAD6 mutation. The
mutation was also observed in an unaffected daughter (age
28) of the proband (Supplementary Figure 1). Three unaffected
siblings at ages 54, 58, and 64 did not carry the mutation. No
gDNA was available from a sister of P99 with unspecified aortic
valve problems. The p.Pro152Profs∗27 mutation was found in
an unaffected daughter (age 39) of P99 but was absent in his 37
year-old unaffected son (Supplementary Figure 1).
We also provide a corrected Figure 2 and Supplementary
Table 2.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fphys.
2017.00730/full#supplementary-material
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